ALLETE (NYSE:ALE – Get Free Report) is expected to issue its Q1 2025 quarterly earnings data before the market opens on Thursday, May 8th. Analysts expect ALLETE to post earnings of $1.01 per share for the quarter.
ALLETE (NYSE:ALE – Get Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The utilities provider reported $0.87 earnings per share for the quarter, missing the consensus estimate of $1.02 by ($0.15). ALLETE had a return on equity of 5.97% and a net margin of 11.72%.
ALLETE Price Performance
Shares of ALE opened at $65.49 on Wednesday. ALLETE has a 1-year low of $61.51 and a 1-year high of $65.99. The firm has a 50-day simple moving average of $65.25 and a two-hundred day simple moving average of $65.07. The stock has a market cap of $3.80 billion, a PE ratio of 21.13 and a beta of 0.82. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.08 and a quick ratio of 0.69.
ALLETE Dividend Announcement
Analyst Ratings Changes
Separately, StockNews.com initiated coverage on ALLETE in a report on Friday, January 10th. They set a “hold” rating for the company.
ALLETE Company Profile
ALLETE, Inc operates as an energy company. The company operates through Regulated Operations, ALLETE Clean Energy, and Corporate and Other segments. It generates electricity from coal-fired, biomass co-fired / natural gas, hydroelectric, wind, and solar. In addition, the company provides regulated utility electric services in northwestern Wisconsin to approximately 15,000 electric customers, 13,000 natural gas customers, and 10,000 water customers, as well as regulated utility electric services in northeastern Minnesota to approximately 150,000 retail customers and 14 non-affiliated municipal customers.
Read More
- Five stocks we like better than ALLETE
- Short Selling – The Pros and Cons
- 3 Mid-Cap Medical Stocks Outperforming the Market
- What is a Death Cross in Stocks?
- The Top-Ranked Insider Buys From April by Market Cap
- Roth IRA Calculator: Calculate Your Potential Returns
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for ALLETE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALLETE and related companies with MarketBeat.com's FREE daily email newsletter.